Genetics of hypercalciuric nephrolithiasis: Renal stone disease

Annals of the New York Academy of Sciences

Volumn 1116, Issue , 2007, Pages 461-484

  Stechman, Michael J ^a   Loh, Nellie Y ^a   Thakker, Rajesh V ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Animal models; Calcium; Hereditary; Idiopathic hypercalciuria; Inheritance; Magnesium; Nephrolithiasis; Phosphate; Renal tubular disorders

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CALCITRIOL; CALCIUM OXALATE; CALCIUM SENSING RECEPTOR; CAVEOLIN 1; CLAUDIN; CLAUDIN 16; OSTEOPONTIN; PROTON PUMP; UNCLASSIFIED DRUG;

ANION TRANSPORT; AUTOSOMAL DOMINANT INHERITANCE; BARTTER SYNDROME; BONE DENSITY; CHROMOSOME; CONFERENCE PAPER; DENT DISEASE; DISEASE MODEL; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HYPERCALCIURIA; HYPOMAGNESEMIA; IDIOPATHIC HYPERCALCIURIA; KIDNEY TUBULE ACIDOSIS; LOWE SYNDROME; MONOGENIC DISORDER; NEPHROLITHIASIS; NONHUMAN; PRIMARY HYPERPARATHYROIDISM; SKELETON MALFORMATION; VITAMIN D RESISTANT RICKETS; X CHROMOSOME RECESSIVE INHERITANCE;

ANIMALIA; RATTUS;

EID: 37249052767     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1402.030     Document Type: Conference Paper

References (114)

1. FRICK, K.K. & D.A. BUSHINSKY. 2003. Molecular mechanisms of primary hypercalciuria. J. Am. Soc. Nephrol. 14: 1082-1095.
2. SCHEINMAN, S.J. 1999. Nephrolithiasis. Semin. Nephrol. 19: 381-388.
3. ROBERTSON, W.G. et al. 1975. Seasonal variations in the composition of urine in relation to calcium stone-formation. Clin. Sci. Mol. Med. 49: 597-602.
4. MOE, O.W. & O. BONNY. 2005. Genetic hypercalciuria. J. Am. Soc. Nephrol. 16: 729-745.
5. PARRY, E.S. & I.S. LISTER. 1975. Sunlight and hypercalciuria. Lancet 1: 1063-1065.
6. CURHAN, G.C. et al. 1997. Family history and risk of kidney stones. J. Am. Soc. Nephrol. 8: 1568-1573.
7. CURHAN, G.C. et al. 1993. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N. Engl. J. Med. 328: 833-838.
8. SERIO, A. & A. FRAIOLI. 1999. Epidemiology of nephrolithiasis. Nephron 81(Suppl 1): 26-30.
9. AUDRAN, M. & E. LEGRAND. 2000. Hypercalciuria. Joint Bone Spine 67: 509-515.
10. CURHAN, G.C. et al. 2001. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men. Kidney Int. 59: 2290-2298.
11. PAK, C.Y. 1997. Nephrolithiasis. Curr. Ther. Endocrinol. Metab. 6: 572-576.
12. POLITO, C. et al. 2000. Idiopathic hypercalciuria and hyperuricosuria: family prevalence of nephrolithiasis. Pediatr. Nephrol. 14: 1102-1104.
13. RESNICK, M., D.B. PRIDGEN & H.O. GOODMAN. 1968. Genetic predisposition to formation of calcium oxalate renal calculi. N. Engl. J. Med. 278: 1313-1318.
14. CLUBBE, W.H. 1894. Family disposition to urinary concretions. Lancet 1: 823.
15. MCGEOWN, M.G. 1960. Heredity in renal stone disease. Clin. Sci. 19: 465-471.
16. TRINCHIERI, A. et al. 1988. Familial aggregation of renal calcium stone disease. J. Urol. 139: 478-481.
17. GOLDFARB, D.S. et al. 2005. A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET) Registry. Kidney Int. 67: 1053-1061.
18. HUNTER, D.J. et al. 2002. Genetic contribution to renal function and electrolyte balance: a twin study. Clin. Sci. (Lond). 103: 259-265.
19. GAUGUIER, D. 2006. Diabetes quantitative trait locus research: from physiology to genetics and back. Diabetologia 49: 431-433.
20. KOTCHEN, T.A. et al. 2002. Identification of hypertension-related QTLs in African American sib pairs. Hypertension 40: 634-639.
21. SHMULEWITZ, D. et al. 2006. Linkage analysis of quantitative traits for obesity, diabetes, hypertension, and dyslipidemia on the island of Kosrae, Federated States of Micronesia. Proc. Natl. Acad. Sci. USA 103: 3502-3509.
22. FRAYLING, T.M. et al. 2007. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316: 889-894.
23. HOOPES, R.R., Jr. et al. 2003. Quantitative trait loci for hypercalciuria in a rat model of kidney stone disease. J. Am. Soc. Nephrol. 14: 1844-1850.
24. BUSHINSKY, D.A. 1999. Genetic hypercalciuric stone-forming rats. Curr. Opin. Nephrol. Hypertens. 8: 479-488.
25. HOOPES, R.R., Jr. et al. 2006. Isolation and confirmation of a calcium excretion quantitative trait locus on chromosome 1 in genetic hypercalciuric stoneforming congenic rats. J. Am. Soc. Nephrol. 17: 1292-1304.
26. FAVUS, M.J. et al. 2004. Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria. J. Clin. Endocrinol. Metab. 89: 4937-4943.
27. KARNAUSKAS, A.J. et al. 2005. Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats. J. Bone Miner. Res. 20: 447-454.
28. YAO, J.J. et al. 2005. Regulation of renal calcium receptor gene expression by 1,25-dihydroxyvitamin D3 in genetic hypercalciuric stone-forming rats. J. Am. Soc. Nephrol. 16: 1300-1308.
29. COE, F.L., J.H. PARKS & E.S. MOORE. 1979. Familial idiopathic hypercalciuria. N. Engl. J. Med. 300: 337-340.
30. REED, B.Y. et al. 1999. Mapping a gene defect in absorptive hypercalciuria to chromosome 1q23.3-q24. J. Clin. Endocrinol. Metab. 84: 3907-3913.
31. SCOTT, P. et al. 1999. Suggestive evidence for a susceptibility gene near the vitamin D receptor locus in idiopathic calcium stone formation. J. Am. Soc. Nephrol. 10: 1007-1013.
32. WOLF, M.T. et al. 2005. Mapping a new suggestive gene locus for autosomal dominant nephrolithiasis to chromosome 9q33.2-q34.2 by total genome search for linkage. Nephrol. Dial. Transplant. 20: 909-914.
33. PAK, C.Y. et al. 1975. A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias. N. Engl. J. Med. 292: 497-500.
34. PAK, C.Y. et al. 1981. Familial absorptive hypercalciuria in a large kindred. J. Urol. 126: 717-719.
35. GENG, W. et al. 2005. Cloning and characterization of the human soluble adenylyl cyclase. Am. J. Physiol. Cell Physiol. 288: C1305-C1316.
36. REED, B.Y. et al. 2002. Identification and characterization of a gene with base substitutions associated with the absorptive hypercalciuria phenotype and low spinal bone density. J. Clin. Endocrinol. Metab. 87: 1476-1485.
37. HEATH, H., III. 1989. Familial benign (hypocalciuric) hypercalcemia. A troublesome mimic of mild primary hyperparathyroidism. Endocrinol. Metab. Clin. North Am. 18: 723-740.
38. CARLING, T. et al. 2000. Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor. J. Clin. Endocrinol. Metab. 85: 2042-2047.
39. WARNER, J. et al. 2004. Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications. J. Med. Genet. 41: 155-160.
40. PEARCE, S.H. et al. 1996. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N. Engl. J. Med. 335: 1115-1122.
41. POLLAK, M.R. et al. 1994. Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation. Nat. Genet. 8: 303-307.
42. FINEGOLD, D.N. et al. 1994. Preliminary localization of a gene for autosomal dominant hypoparathyroidism to chromosome 3q13. Pediatr. Res. 36: 414-417.
43. PERRY, Y. et al. 1994. A missense mutation in the Ca-sensing receptor causes familial autosomal dominant hypoparathyroidism. Am. J. Hum. Genet. 55: A17.
44. BARON, J. et al. 1996. Mutations in the Ca(2+)-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism. Hum. Mol. Genet. 5: 601-606.
45. HENDY, G.N. et al. 2000. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Hum. Mutat. 16: 281-296.
46. THAKKER, R.V. 2000. Molecular pathology of renal chloride channels in Dent's disease and Bartter's syndrome. Exp. Nephrol. 8: 351-360.
47. HEBERT, S.C. 2003. Bartter syndrome. Curr. Opin. Nephrol. Hypertens. 12: 527-532.
48. WATANABE, S. et al. 2002. Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Lancet 360: 692-694.
49. VARGAS-POUSSOU, R. et al. 2002. Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. J. Am. Soc. Nephrol. 13: 2259-2266.
50. BESBAS, N. et al. 2005. CLCN5 mutation (R347X) associated with hypokalaemic metabolic alkalosis in a Turkish child: an unusual presentation of Dent's disease. Nephrol. Dial. Transplant. 20: 1476-1479.
51. WRONG, O.M., A.G. NORDEN & T.G. FEEST. 1994. Dent's disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance. QJM 87: 473-493.
52. LLOYD, S.E. et al. 1996. A common molecular basis for three inherited kidney stone diseases. Nature 379: 445-449.
53. JENTSCH, T.J., I. NEAGOE & O. SCHEEL. 2005. CLC chloride channels and transporters. Curr. Opin. Neurobiol. 15: 319-325.
54. GUNTHER, W. et al. 1998. ClC-5, the chloride channel mutated in Dent's disease, colocalizes with the proton pump in endocytotically active kidney cells. Proc. Natl. Acad. Sci. USA 95: 8075-8080.
55. DEVUYST, O. et al. 1999. Intra-renal and subcellular distribution of the human chloride channel, CLC-5, reveals a pathophysiological basis for Dent's disease. Hum. Mol. Genet. 8: 247-257.
56. PIWON, N. et al. 2000. ClC-5 Cl - channel disruption impairs endocytosis in a mouse model for Dent's disease. Nature 408: 369-373.
57. GUNTHER, W., N. PIWON & T.J. JENTSCH. 2003. The ClC-5 chloride channel knockout mouse - an animal model for Dent's disease. Pflugers Arch. 445: 456-462.
58. HOOPES, R.R., Jr. et al. 2005. Dent disease with mutations in OCRL1. Am. J. Hum. Genet. 76: 260-267.
59. SLIMAN, G.A. et al. 1995. Hypercalciuria and nephrocalcinosis in the oculocerebrorenal syndrome. J. Urol. 153: 1244-1246.
60. LEAHEY, A.M., L.R. CHARNAS & R.L. NUSSBAUM. 1993. Nonsense mutations in the OCRL-1 gene in patients with the oculocerebrorenal syndrome of Lowe. Hum. Mol. Genet. 2: 461-463.
61. ZHANG, X. et al. 1998. Cell lines from kidney proximal tubules of a patient with Lowe syndrome lack OCRL inositol polyphosphate 5-phosphatase and accumulate phosphatidylinositol 4,5-bisphosphate. J. Biol. Chem. 273: 1574-1582.
62. UNGEWICKELL, A.J. & P.W. MAJERUS. 1999. Increased levels of plasma lysosomal enzymes in patients with Lowe syndrome. Proc. Natl. Acad. Sci. USA 96: 13342-13344.
63. LOWE, M. 2005. Structure and function of the Lowe syndrome protein OCRL1. Traffic 6: 711-719.
64. PRIE, D. et al. 2002. Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter. N. Engl. J. Med. 347: 983-991.
65. VIRKKI, L.V. et al. 2003. Functional characterization of two naturally occurring mutations in the human sodium-phosphate cotransporter type IIa. J. Bone Miner. Res. 18: 2135-2141.
66. BECK, L. et al. 1998. Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc. Natl. Acad. Sci. USA 95: 5372-5377.
67. TIEDER, M. et al. 1985. Hereditary hypophosphatemic rickets with hypercalciuria. N. Engl. J. Med. 312: 611-617.
68. JONES, A. et al. 2001. Hereditary hypophosphatemic rickets with hypercalciuria is not caused by mutations in the Na/Pi cotransporter NPT2 gene. J. Am. Soc. Nephrol. 12: 507-514.
69. BERGWITZ, C. et al. 2006. SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis. Am. J. Hum. Genet. 78: 179-192.
70. LORENZ-DEPIEREUX, B. et al. 2006. Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3. Am. J. Hum. Genet. 78: 193-201.
71. PAUNIER, L. et al. 1968. Primary hypomagnesemia with secondary hypocalcemia in an infant. Pediatrics 41: 385-402.
72. SIMON, D.B. et al. 1999. Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science 285: 103-106.
73. WEBER, S. et al. 2001. Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J. Am. Soc. Nephrol. 12: 1872-1881.
74. MULLER, D. et al. 2003. A novel claudin 16 mutation associated with childhood hypercalciuria abolishes binding to ZO-1 and results in lysosomal mistargeting. Am. J. Hum. Genet. 73: 1293-1301.
75. COLEGIO, O.R. et al. 2002. Claudins create charge-selective channels in the paracellular pathway between epithelial cells. Am. J. Physiol. Cell Physiol. 283: C142-C147.
76. KONRAD, M., K.P. SCHLINGMANN & T. GUDERMANN. 2004. Insights into the molecular nature of magnesium homeostasis. Am. J. Physiol. Renal Physiol. 286: F599-F605.
77. KONRAD, M. et al. 2006. Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am. J. Hum. Genet. 79: 949-957.
78. KOPITO, R.R. 1990. Molecular biology of the anion exchanger gene family. Int. Rev. Cytol. 123: 177-199.
79. TANNER, M.J. 1993. Molecular and cellular biology of the erythrocyte anion exchanger (AE1). Semin. Hematol. 30: 34-57.
80. WAGNER, S. et al. 1987. Immunochemical characterization of a band 3-like anion exchanger in collecting duct of human kidney. Am. J. Physiol. 253: F213-F221.
81. BRUCE, L.J. et al. 1997. Familial distal renal tubular acidosis is associated with mutations in the red cell anion exchanger (Band 3, AE1) gene. J. Clin. Invest. 100: 1693-1707.
82. BRUCE, L.J. et al. 2000. Band 3 mutations, renal tubular acidosis and South-East Asian ovalocytosis in Malaysia and Papua New Guinea: loss of up to 95% band 3 transport in red cells. Biochem. J. 350(Pt 1): 41-51.
83. TOYE, A.M. 2005. Defective kidney anion-exchanger 1 (AE1, Band 3) trafficking in dominant distal renal tubular acidosis (dRTA). Biochem. Soc. Symp. 72: 47-63.
84. WRONG, O. et al. 2002. Band 3 mutations, distal renal tubular acidosis, and Southeast Asian ovalocytosis. Kidney Int. 62: 10-19.
85. KARET, F.E. et al. 1999. Mutations in the gene encoding B1 subunit of H+-ATPase cause renal tubular acidosis with sensorineural deafness. Nat. Genet. 21: 84-90.
86. NELSON, R.D. et al. 1992. Selectively amplified expression of an isoform of the vacuolar H(+)-ATPase 56-kilodalton subunit in renal intercalated cells. Proc. Natl. Acad. Sci. USA 89: 3541-3545.
87. STANKOVIC, K.M. et al. 1997. Localization of pH regulating proteins H+ATPase and Cl-/HCO3- exchanger in the guinea pig inner ear. Hear Res. 114: 21-34.
88. SMITH, A.N. et al. 2000. Mutations in ATP6N1B, encoding a new kidney vacuolar proton pump 116-kD subunit, cause recessive distal renal tubular acidosis with preserved hearing. Nat. Genet. 26: 71-75.
89. STOVER, E.H. et al. 2002. Novel ATP6V1B1 and ATP6V0A4 mutations in autosomal recessive distal renal tubular acidosis with new evidence for hearing loss. J. Med. Genet. 39: 796-803.
90. PARTON, R.G. 1996. Caveolae and caveolins. Curr. Opin. Cell Biol. 8: 542-548.
91. CAO, G. et al. 2003. Disruption of the caveolin-1 gene impairs renal calcium reabsorption and leads to hypercalciuria and urolithiasis. Am. J. Pathol. 162: 1241-1248.
92. FUJIMOTO, T. 1993. Calcium pump of the plasma membrane is localized in caveolae. J. Cell Biol. 120: 1147-1157.
93. SHAUL, P.W. & R.G. ANDERSON. 1998. Role of plasmalemmal caveolae in signal transduction. Am. J. Physiol. 275: L843-L851.
94. JIANG, Z. et al. 2006. Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6. Nat. Genet. 38: 474-478.
95. CHAU, H. et al. 2003. Renal calcification in mice homozygous for the disrupted type IIa Na/Pi cotransporter gene Npt2. J. Bone Miner. Res. 18: 644-657.
96. SAYER, J.A., G. CARR & N.L. SIMMONS. 2004. Nephrocalcinosis: molecular insights into calcium precipitation within the kidney. Clin. Sci (Lond). 106: 549-561.
97. WATTS, R.W. 2005. Idiopathic urinary stone disease: possible polygenic aetiological factors. QJM 98: 241-246.
98. WESSON, J.A. et al. 2003. Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules. J. Am. Soc. Nephrol. 14: 139-147.
99. HSU, Y.J., J.G. HOENDEROP & R.J. BINDELS. 2007. TRP channels in kidney disease. Biochim. Biophys. Acta. doi: 10.1016/j.bbadis.2007.02.001.
100. HOENDEROP, J.G. et al. 2001. Function and expression of the epithelial Ca(2+) channel family: comparison of mammalian ECaC1 and 2. J. Physiol. 537: 747-761.
101. HOENDEROP, J.G. et al. 2003. Renal Ca2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5. J. Clin. Invest. 112: 1906-1914.
102. CHANG, Q. et al. 2005. The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel. Science 310: 490-493.
103. KURO-O, M. et al. 1997. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390: 45-51.
104. HOENDEROP, J.G., B. NILIUS & R.J. BINDELS. 2005. Calcium absorption across epithelia. Physiol. Rev. 85: 373-422.
105. TSUJIKAWA, H. et al. 2003. Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol. Endocrinol. 17: 2393-2403.
106. SIMON, D.B. et al. 1996. Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat. Genet. 13: 183-188.
107. SIMON, D.B. et al. 1996. Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK. Nat. Genet. 14: 152-156.
108. ZELIKOVIC, I. et al. 2003. A novel mutation in the chloride channel gene, CLCNKB, as a cause of Gitelman and Bartter syndromes. Kidney Int. 63: 24-32.
109. ESTEVEZ, R. et al. 2001. Barttin is a Cl- channel beta-subunit crucial for renal Cl-reabsorption and inner ear K+ secretion. Nature 414: 558-561.
110. DANPURE, C.J. 2004. Molecular aetiology of primary hyperoxaluria type 1. Nephron. Exp. Nephrol. 98: e39-e44.
111. CAMERON, J.S., F. MORO & H.A. SIMMONDS. 1993. Gout, uric acid and purine metabolism in paediatric nephrology. Pediatr. Nephrol. 7: 105-118.
112. GOODYER, P. 2004. The molecular basis of cystinuria. Nephron. Exp. Nephrol. 98: e45-e49.
113. WIEBERS, D.O. et al. 1979. Renal stones in Wilson's disease. Am. J. Med. 67: 249-254.
114. VERNON, H.J. et al. 2005. Aprt/Opn double knockout mice: osteopontin is a modifier of kidney stone disease severity. Kidney Int. 68: 938-947.